This application claims the benefit and priority of European Application Serial No. 18189498.1, filed Aug. 17, 2018, which is incorporated herein by reference.
Generally, the present disclosure relates to the technical field of sample analysis, such as the assay of chemical or biochemical reactions, and more particular to the technical field of high throughput analysis of biological samples. In more detail, the present disclosure is directed to a microfluidic system for digital polymerase chain reaction (dPCR) of a biological sample. In further detail, such system comprises a microfluidic device with a flow channel in fluid communication with an array of reaction areas, also often referred to as partitions implemented as reaction chambers or reaction vessels, for example in the form of wells or microwells, which are functioning as reaction sites for chemical or biological reactions of at least one biological sample provided therein, respectively, and which system can achieve a desired thermocycling temperature profile in the microfluidic device as fast and as reliable as possible. Further, the present disclosure relates to a respective method for dPCR of a biological sample in such a microfluidic system.
In the field of diagnostic technology for the assay of chemical or biochemical reactions, it is a goal to be able to carry out multiple different assays on one or more test samples on the same —preferably disposable—microfluidic device, thereby providing methods of independently analyzing one or more test samples with multiple different reagents in the course of a single analytical process. As such test samples, biological samples are usually used, which are often taken from patients by medical personnel for laboratory analysis, e.g. for determining concentration levels of different components within the taken samples.
Accordingly, the terms “sample” and “biological sample” refer to material(s) that may potentially contain an analyte of interest, wherein the sample can be derived from any biological source, such as a physiological liquid, including blood, saliva, ocular lens liquid, cerebrospinal liquid, sweat, urine, stool, semen, milk, ascites liquid, mucous, synovial liquid, peritoneal liquid, amniotic liquid, tissue, cultured cells, or the like, wherein the sample can particularly be suspected to contain a certain antigen or nucleic acid.
Most of the known chemical, biochemical and/or biological assays include immobilizing a biological sample as mentioned above within reaction sites, and performing one or more reactions with the immobilized sample material, followed by a quantitative and/or qualitative analytical process. Here, for many biological, biochemical, diagnostic or therapeutic applications, it is essential to be able to accurately determine the amount or concentration of a certain substance or compound in the biological sample, i.e. of the analyte of interest. In order to be able to achieve this goal as accurately as possible, different methods have been developed over the years in this technical field, such as the widely known Polymerase Chain Reaction (PCR) method, which enables the in vitro synthesis of nucleic acids in a biological sample, through which a DNA segment can be specifically replicated, i.e. a cost-effective way to copy or amplify small segments of DNA or RNA in the sample. The development of such methods for amplifying DNA or RNA segments has generated enormous benefits in gene analysis as well as the diagnosis of many genetic diseases, or also in the detection of viral load.
Usually, thermal cycling, also referred to as thermocycling, is utilized to provide heating and cooling of the reactants in the sample within the reaction chamber for amplifying such DNA or RNA segments, wherein laboratory instruments including thermocyclers are commonly used in order to achieve an automatic procedure of diagnostic assays based on PCR, in which, during a PCR conduct, the liquid PCR-samples have to be heated and cooled to differing temperature levels repeatedly and have to be maintained for a certain amount of time at different temperature plateaus. As an example, in the course of a typical PCR conduct, a specific target nucleic acid is amplified by a series of reiterations of a cycle of steps in which nucleic acids present in the reaction mixture are (a) denatured at relatively high temperatures, for example at a denaturation temperature of more than 90° C., usually about 94° C. to 95° C., for separation of the double-stranded DNA, then (b) the reaction mixture is cooled down to a temperature at which short oligonucleotide primers bind to the single stranded target nucleic acid, for example at an annealing temperature of about 52° C. to 56° C. for primer binding at the separated DNA strands in order to provide templates (annealing), and, thereafter, (c) the primers are extended/elongated using a polymerase enzyme, for example at an extension temperature at about 72° C. for creation of new DNA strands, so that the original nucleic acid sequence is replicated. Repeated cycles of denaturation, annealing and extension, usually about 25 to 30 repeated cycles, result in the exponential increase in the amount of target nucleic acid present in the sample. Now, in order to be able to accurately maintain such temperature plateaus during thermocycling, a uniform temperature distribution over the reaction zone should be maintained, so that all reaction areas can be heated and cooled uniformly to obtain uniform sample yields between the reaction areas containing the sample. For carrying out a regular PCR method, commonly known thermocycling devices, such as thermal cyclers/thermocyclers, for amplifying DNA segments can be used, which basically consist of a mount for receiving the samples, often also referred to as a sample tempering mount, and a heat pump attached to the mount, which heat pipe is often provided in the form of a combination of a Peltier element used for active heating and cooling of the mount and, thus, for actively controlling the temperature provided to the samples, and a respective heat sink thermally coupled to the Peltier element in order to dissipate the heat away and, for example, into the ambient environment.
Generally, the basic need exists to keep making diagnostic assays faster, cheaper and simpler to perform, while achieving high precision along with increasing efficiency of conventional laboratory processes. One particular example of the mentioned methods for amplifying DNA or RNA segments —being in the focus of the present disclosure-is the digital polymerase chain reaction method, also referred to as digital PCR or dPCR, which denotes a biotechnology refinement of the conventional PCR method as described above, and which can be used to directly quantify and clonally amplify nucleic acids including DNA, cDNA or RNA. Here, the substantial difference between dPCR and traditional PCR substantially lies within the method of measuring nucleic acids amounts, since traditional PCR carries out one reaction per single sample, whereas dPCR carries out a single reaction within a sample separated into a large number of partitions provided in a respectively large number of reaction areas, wherein the reaction is carried out in each reaction area individually such that a more reliable collection and sensitive measurement of nucleic acid amounts becomes possible. Accordingly, substantial effort has been made in order to achieve miniaturization and integration of various assay operations, for increasing the number of parallel assays on one single carrier device. As an example of such a single carrier device, microfluidic devices, such as microfluidic chips, have been developed, which provide microscale channels and microscale reaction areas receiving microliter or nanoliter-scale samples in the form of streamable sample liquid, such as aqueous sample liquid. Microliter-scale reagents, typically filled in advance into an array of small wells, i.e. microwells or nanowells provided as reaction areas on the microfluidic chip, are placed therein for contacting a stream of sample liquid streamed through a flow channel, wherein each type of assay is dependent on the reagents loaded into the array of reaction areas as well as the configuration of flow channels and detectors, wherein the filling of sample liquid into the microfluidic chip can be implemented by means of pipetting the sample liquid into the chip. This advanced technology allows a plurality of assays to be carried out simultaneously on a miniaturized scale. Most of these chemical, biochemical and/or biological assays are directed to the immobilization of biological materials such as polypeptides and nucleic acids, cells or tissues within the wells and the performance of one or more reactions with the immobilized material, followed by a quantitative and/or qualitative analytical process, such as luminescence test measurements. For illustrative purposes,
However, when actually miniaturizing the reaction chamber volumes to become microfluidic structures of a microfluidic device in order to generate the desired small dimensions, several already known problems increase, such as problems related to the increased surface-to-volume ratio, or undesired sample liquid vaporization, and in particular the undesired generation of gas bubbles within the liquid provided in or streamed through the microfluidic device. Lying in the focus of the present disclosure, gas bubbles existent in a liquid within a microfluidic structure can constitute a severe problem since gas bubbles circulating through a microfluidic system can—as a side aspect-not only damage the microfluidic structure of any kind of sensor used therein, but mainly can also damage the biological sample of interest due to causing undesired mixing of samples in neighboring microwells, resulting in cross-contamination and, thus, substantial experimental errors and false assay results. For example, gas bubbles can cause experimental errors to chromatography columns by letting reaction components within the reaction areas dry out. Also, gas bubbles can severely affect optical detection of the reaction areas and the reactions occurring therein, potentially resulting in failed assays. In particular when performing dPCR of samples in the microfluidic device, gas bubbles, such as air bubbles, have a tendency to occur frequently, due to several reasons:
For illustrative reasons regarding the mentioned gas bubble generation and growth,
Accordingly, during filling, “initial” gas bubbles 91 might be trapped inside the chip 7, for example within sample liquid inside a microwell, or within sealing liquid provided inside the flow channel of the chip 7. As can be seen in
So far, there have been different approaches to solve the problem of gas bubbles in the flow channel of a microfluidic device. As is, for example, described in EP 2 830 769 A1, one solution to the problem of gas bubbles is to prevent gas bubbles getting introduced into the microfluidic device during filling by providing certain microfluidic structures after an inlet, such as the provision of a slit formed along an entire edge of a substrate where fluids can flow from an inlet manifold through the slit, around substantially the entire edge of the substrate, and into a reaction chamber at equalized pressure and without gas bubbles. Here, however, a substantial disadvantage of such a solution is that if such microfluidic structures fail to prevent gas bubbles to enter the microfluidic device, the gas bubble can end up in the reaction chamber and can grow due to vaporization of sample at increased cycling temperature, without any means to remove the entered gas bubble. Also, a new gas bubble can emerge due to vaporization of sample at increased cycling temperatures, resulting in that the dPCR method will fail. Accordingly, even though the provided known solution may be more or less effective for avoiding already existing gas bubbles to enter the microfluidic device, still entered gas bubbles or newly generated gas bubbles can not be handled during thermocycling.
Another solution to the problem of gas bubbles is known from, for example, US 2005/0009101 A1, which describes microfluidic cassettes or devices that can be used to effect a number of manipulations on a sample to ultimately result in target analyte detection or quantification, wherein a light pipe is provided that enables detection of bubbles formed in hybridization fluid or wash buffer, and wherein a roller is provided in functional relationship with a flexible layer, in the sense of a peristaltic interaction, in order to remove any detected bubbles, wherein an elastomeric material of the flexible layer is used as peristaltic-operative material. Accordingly, the provided solution is directed to a kind of squeezing any kind of bubbles out of the microfluidic device, which, however, requires an elastomeric fluidic chip material. Such solution, however, is considered to be not suitable for dPCR chip, since handling and filling of such flexible chip material is ineffective and only imprecise, and surface modifiability as well as optical quality of such material is poor, compared to the usually used inflexible chip materials.
As a further solution to the problem of gas bubbles inside a microfluidic device caused by vaporization of sample liquid, pressure can be applied to the microfluidic device, such as is described in, for example, US 2005/0148066 A1, in which an apparatus for conducting multiple simultaneous micro-volume chemical and bio chemical reactions in an array format is disclosed. Here, the apparatus is thermal cycled in a thermal cycler with a groove across its surface, so that a thin microhole chip can be inserted into the groove and is thermal cycled, wherein a thin heat-conductive silicone pad can be used to provide thermal contact as well as pressure to the surfaces of the microhole chip in order to prevent vaporization of the samples inside the array and, thus, preventing the generation or growth of gas bubbles. Here, with such a solution, a substantial disadvantage is the higher complexity of the overall instrumental structure as well as the additional structural complexity required by the application of pressure to the chip.
Therefore, the general need exists in the technical field of dPCR assay to provide a microfluidic system and respective method for dPCR of a biological sample exhibiting an improved solution for avoiding and/or removing gas bubbles inside the flow channel while maintaining or even improving thermocycling efficiency of the microfluidic system.
In a specific embodiment, the disclosure provides a microfluidic system for digital polymerase chain reaction (dPCR) of a biological sample, the microfluidic system comprising:
at least one microfluidic device having an inlet, an outlet, a flow channel connecting the inlet to the outlet, and an array of reaction areas in fluidic communication with the flow channel;
a flow circuit connectable to the microfluidic device, for flowing liquid through the flow channel of the microfluidic device;
a sample liquid source connectable to the microfluidic device, for providing the microfluidic device with a sample liquid;
a primary sealing liquid source connectable to the microfluidic device, for providing the microfluidic device with initial sealing liquid for sealing the sample liquid inside the array of reaction areas;
a secondary sealing liquid source connectable to the microfluidic device, for providing the microfluidic device with additional sealing liquid, and
a pumping device connected to the flow circuit and adapted to pump said additional sealing liquid through the flow channel.
Also provided is a method for digital polymerase chain reaction (dPCR) of a biological sample in a microfluidic system as described herein, the method comprising:
flowing a sample liquid through the flow channel of the microfluidic device, thereby filling the array of reaction areas with the sample liquid in a successive manner by pushing the sample liquid through the flow channel;
flowing an initial sealing liquid through the flow channel of the microfluidic device for sealing each reaction area of the array of reaction areas after the microfluidic device has been filled with the sample liquid, thereby pushing remaining sample liquid out of the microfluidic device,
applying a thermocycling temperature profile to the array of reaction areas, and
pumping additional sealing liquid through the flow channel of the microfluidic device, thereby flushing gas bubbles out of the flow channel.
The inventors of the present disclosure can confirm that gas bubbles can cause severe problems in regard to successfully completing the thermocycling of the samples, and can, thus, lead to substantial assay failure. It has also been found that the previously proposed solutions are not entirely sufficient or satisfactory in regard to the avoidance of such gas bubbles. In particular, the already proposed solutions in the prior art (see above) were either too costly or not sufficient to generate reproducible test results. Accordingly, the introduction of gas bubbles into a flow channel of a microfluidic device as well as generation of new gas bubbles and gas bubble growth during tempering must be avoided, and a new and improved solution was necessary. Thus, a new and inventive solution was developed by the inventors, basically based on the idea of removing already existing or emerging gas bubbles by “flushing” the microfluidic chip with separation fluid, i.e. with sealing liquid, due to the fact that sealing liquid —when streamed through the flow channel-can reliably flush any gas bubbles through the flow channel and out of the outlet port of a microfluidic chip. Thus, the present disclosure addresses the above described problems of simplified and more effective avoidance and/or removal of gas bubbles inside a flow channel of a microfluidic device within a microfluidic system, while improving thermocycling efficiency thereof.
According to a first aspect of the present disclosure, a microfluidic system for dPCR of a biological sample is provided, for example used for assaying biological sample provided in the form of sample liquid, such as a polar aqueous sample solution, to individual reaction areas of an array of reaction areas, wherein the microfluidic system comprises at least one microfluidic device having an inlet, an outlet, a flow channel connecting the inlet to the outlet, and an array of reaction areas in fluidic communication with the flow channel. Here, the microfluidic device can exhibit a structure consisting of at least a top layer and a bottom layer, wherein either the top layer or the bottom layer can provide the array of reaction areas, the inlet and the outlet. The flow channel is established between the top layer and the bottom layer and is in fluid connection with the array of reaction areas which can be implemented in the form of microwells or nanowells, thereby rendering the microfluidic device to be, for example, a microfluidic chip. For example, the width of the entire flow channel, also referred to as lane width, can reside in a range between 6 mm and 7 mm, such as 6.4 mm, which usually provides space in width for about 60 to 100 wells next to each other, i.e. in a lateral direction of the flow channel. Further, the cross-sectional area of an opening of each well can have a circular shape, an oval shape, or a polygonal shape, such as a hexagonal shape. With a polygonal shape of the well opening, and particularly with a hexagonal shape of the well opening, it becomes possible to arrange the well openings to each other with less distance in between, i.e. achieve an increased density of distribution of well openings inside the flow channel. Accordingly, the number of wells in the array of wells of the plate can be further maximized. Moreover, a width of the well opening, including an intermediate space between wells, can be 60 μm≤w≤110 μm, such as 62 μm (small well)≤w≤104 μm (big well). Further, the microfluidic system comprises a flow circuit connectable to the microfluidic device, for flowing liquid through the flow channel of the microfluidic device, and a sample liquid source connectable to the microfluidic device, for providing the microfluidic device with a sample liquid, for example by means of the flow circuit. As material for the microfluidic device, i.e. for the device layers, materials such as cyclic olefin copolymer (COC), cyclic olefin polymer (COP), or the like can be used, wherein the use of COP is preferable, for example due to cost considerations. Further, the flow circuit can be implemented by means of a tubing system, for example a flexible tubing system consisting of one or several flexible tubes, which tubes can be made of an inner layer of ethylene propylene diene monomer (EPDM) rubber and an outer layer of nitrile butadiene (NBR) rubber, potentially also enforced with a synthetic mesh, or can be generally made of EPDM, NBR, fluorinated ethylene-propylene polymer (FEP), Polytetrafluoroethylene (PTFE), Polyvinyl chloride (PVC), polyethersulfone (PES), fluoroelastomer (FKM), silicone, and can additionally be jacketed by means of a heat isolating material.
Moreover, the microfluidic system of the present disclosure comprises a primary sealing liquid source connectable to the microfluidic device, for providing the microfluidic device with initial or primary sealing liquid for sealing the sample liquid inside the array of reaction areas, wherein the initial sealing liquid can be an untempered sealing liquid, i.e. an unheated sealing liquid, for example provided at or around ambient temperature. Furthermore, the microfluidic system of the present disclosure comprises a secondary sealing liquid source connectable to the microfluidic device, for providing the microfluidic device with additional sealing liquid, and a pumping device connected to the flow circuit and adapted to pump the additional sealing liquid through the flow channel. As an example, the pumping device of the present disclosure can be one of a peristaltic pump, a metering pump or a syringe pump, or, alternatively—with additional fluidic components such as valves or the like—the pumping device of the present disclosure can be any other type of pump, e.g. a diaphragm pump, a wobble piston pump, a micro gear pump, or the like. Further, as an example of the connectability between the microfluidic device and the connectable components of the microfluidic system of the present disclosure, the inlet and/or the outlet of the microfluidic device can be implemented in the form of a single connection port, respectively, such as a circular fluidtight port, for example in the form of a Luer Lock adapter or the like, for connection of the microfluidic device with the sample liquid source, for connection of the microfluidic device with the primary sealing liquid source, or for connection of the microfluidic device with the secondary sealing liquid source.
With the above described combination of sealing liquid source and pumping device of the microfluidic system of the present disclosure, and the possibility of pumping additional sealing liquid through the flow channel, gas bubbles already existing inside the flow channel, or any kind of gas bubbles emerging during thermocycling of the sample inside the microfluidic device, can be removed from the microfluidic device by flushing the flow channel with additional sealing liquid. Accordingly, with the present disclosure, the negative influence of gas bubbles on the test results can at least be reduced or can be entirely avoided, thereby resulting in a significantly improved microfluidic system.
In other words, the present disclosure is concerned with the general technical field of PCR using a well plate-based thermocycling structure, with the main focus on endpoint digital PCR. More specifically, the well plate is provided within a microfluidic chip in the form of a microwell plate or even a nanowell plate featuring several thousands of nanowells. Here, the microfluidic chip can be a disposable with the flow channel in the form of a closed filling channel on the side of the openings of the wells that is connected with the macroscopic filling inlet port on one side and an overflow outlet port on the other side. Also, the disposable microfluidic chip may contain more than one array of reaction areas with such a microwell structure and, accordingly, more than one filling channel on the side of the openings. Usually, the microfluidic chip can be prefilled with a so-called PCR-mastermix, mixed with the target mix in form of the sample liquid. Afterwards, the flow channel on the side of the openings of the microwells is being filled with sealing liquid, for example cover oil, in order to prevent the sample liquid in the microwells from evaporating during thermocycling, and to avoid the sample to migrate from well to well. Here, the oil can be filled into the flow channel using, for example, peristaltic pumps applying a pressure of about 500 mbar. Finally, the microfluidic system of the present disclosure can feature different sensors that perform filling checks, correct placement checks, and the like.
According to a specific embodiment of the dPCR microfluidic system of the present disclosure, the initial sealing liquid and the additional sealing liquid consist of one and the same sealing liquid material, meaning that any sealing liquid used with the microfluidic system of the present disclosure can be the same sealing liquid type. Further, any sealing liquid has to be immiscible with the sample liquid. As such immiscible liquid, an oil liquid or a polymer liquid can be used, e.g. a silicone liquid, such as a polydimethylsiloxane (PDMS) liquid, or a mixture of an oil liquid and a polymer liquid. Moreover, the initial sealing liquid and the additional sealing liquid can be provided by different sealing liquid sources, or alternatively by the same sealing liquid source, meaning that the initial sealing liquid source and the secondary sealing liquid source can be implemented by different sealing liquid reservoirs, or alternatively by a common sealing liquid reservoir. Specifically in the case that the initial sealing liquid and the additional sealing liquid consist of one and the same sealing liquid material or type, the primary sealing liquid source and the secondary sealing liquid source can be implemented by one common sealing liquid reservoir, wherein, in this case, the terms “primary” and “secondary” merely refer to the functionality of the common sealing liquid reservoir, i.e. the common sealing liquid reservoir can function as primary sealing liquid source for providing the initial sealing liquid which primarily seals the sample inside the array of reaction areas of the microfluidic device, and can then function as secondary sealing liquid source for providing additional sealing liquid for flushing any gas bubbles out of the flow channel of the microfluidic device. Such configuration can be chosen due to the fact that the complexity of the structure of the microfluidic system can be reduced, compared to the provision of two different sealing liquid reservoirs.
According to a further specific embodiment of the dPCR microfluidic system of the present disclosure, the pumping device can be controlled by a control unit to pump the additional sealing liquid through the flow channel on demand, for flushing gas bubbles out of the flow channel. Here, the control unit can be triggered by hand by an operator, or automatically, e.g. based on a feedback signal from an additional system component detecting or monitoring the occurrence of gas bubbles inside the flow channel. Also, the control unit can instruct the pumping device to pump additional sealing liquid through the flow channel based on a predetermined pattern, for example based on the thermocycling steps to be applied to the sample liquid inside the reaction areas. Here, it can be advantageous that the pumping device is controlled to pump a predetermined amount of the additional sealing liquid through the flow channel, wherein the pumping device can be controlled to pump the additional sealing liquid through the flow channel either constantly, intermittently, or upon detection of gas bubbles in the flow channel.
According to a further specific embodiment of the dPCR microfluidic system of the present disclosure, the microfluidic system can further comprise a bubble trap connected to the flow circuit, for separation of air from sealing liquid, the bubble trap being arranged downstream of the outlet of the microfluidic device. Thereby, any gas bubbles flushed-out of the flow channel of the microfluidic device by means of the streamed additional sealing liquid can be removed from the sealing liquid flowing in the flow circuit. Accordingly, the optional bubble trap can be arranged in the fluid path of sealing liquid as provided by the flow circuit, in order to separate air bubbles from the streamed sealing liquid. Thereby, gas bubbles can immediately be removed from the microfluidic system of the present disclosure, without the necessity to collect the sealing fluid exiting the microfluidic device and extract any gas bubbles therefrom.
According to another specific embodiment of the dPCR microfluidic system of the present disclosure, the sample liquid can be an aqueous solution comprising the biological sample and reagents required for the dPCR assay, wherein first the sample liquid can be streamed through the flow channel into the array of reaction areas, in order to fill each reaction area with sample liquid. Afterwards, i.e. after the provision of the sample liquid to the array of reaction areas, the initial sealing liquid is streamed into the flow channel of the microfluidic device, in order to seal the sample liquid inside the reaction areas.
According to a further specific embodiment of the dPCR microfluidic system of the present disclosure, the microfluidic system can further comprise a detection means for detecting the presence or generation of gas bubbles in the microfluidic device, such as an optical imaging device, for example an optical camera, which can detect and/or monitor the presence or generation of gas bubbles inside the flow channel before and during thermocycling, provided that the flow channel allows an optical monitoring. Here, for example, the inside of the flow channel can be made visible from the outside, for example by means of a viewing window, transparent walls of the flow channel, or the like. Accordingly, the detection device can be used to provide a feedback signal indicating the occurrence of gas bubbles inside the flow channel, wherein the control unit can be triggered based on such feedback signal. Thus, with such a structure, the microfluidic system can work automatically, without the necessity of an operator monitoring the microfluidic device during thermocycling or the like.
In order to be able to provide the sample material inside the reaction areas with a thermocycling temperature profile, the microfluidic system can comprise a thermal mount receiving the microfluidic device, for providing a thermocycling temperature profile to the array of reaction areas. For example, a thermal structure as described in correlation with any one of
When using one of (a) and (b), or a combination thereof, the pumping device must be adapted to be able to follow the desired dPCR cycles, i.e. place the respectively tempered additional sealing liquid over the sample array and again away from it, and pump any amount of additional sealing fluid through the flow channel in order to remove gas bubbles. In case of using option (c), i.e. in case the sealing liquid is heated electrically, the liquid should be an electrically conductive liquid which provides a suitable resistance so that it heats up during the current flow. Here, a graphene solution is suitable for such application. In such case, however, the sealing liquid can not be cooled down electrically; instead, either the reservoir or the microfluidic chip itself must be cooled in case the sample temperature during dPCR needs to decrease. Furthermore, if the electrical heating solution is applied, a circular sealing liquid system could be used, without the necessity of reservoirs, which would require a precise control of the dPCR cycles, for example by means of a comprehensive sensor structure monitoring the temperatures and currents in real-time.
According to a further specific embodiment of the dPCR microfluidic system of the present disclosure, the microfluidic system can additionally comprise a pressure chamber surrounding at least the microfluidic device. Here, the functionality of such an additional pressure chamber can add to the already achieved avoidance or removal of gas bubbles occurring inside the microfluidic system of the present disclosure, thereby further ensuring that gas bubbles cannot disturb the assay results. For the thermocycling itself, the disposable microfluidic device including the oil filled ports can thus be set under pressure of 1 to 2 bar, for example around 1.5 bar, in order to further suppress bubble generation during thermocycling. Here, the pressure is preferably applied onto the inside of the microfluidic device by arranging the entire microfluidic device inside the pressure chamber.
According to a further specific embodiment of the present disclosure, the inventive device can further comprise at least one sensor for controlling the temperature at the biological samples received in the microfluidic device, wherein such sensor can be a temperature sensor, for example in combination with a fluid flow sensor. Thus, by providing a respective sensor at any of the components of the inventive microfluidic system, the temperature of the biological samples during dPCR can be monitored closely, and the heating/cooling function of the microfluidic system can be controlled based on the measured temperature values of the samples, in order to regulate the different temperature plateaus of the dPCR accurately and efficiently. Accordingly, such sensor(s), for example temperature sensors, enable a precise control of the thermocycling temperature by a control algorithm or the like, wherein temperature sensors, and other sensors are used to control the respective heating/cooling rate, wherein the heating/cooling power can be significantly varied by changing fluid pumping speed.
According to another aspect of the present disclosure, a method for dPCR of a biological sample in a microfluidic system as described above is provided, the method comprising a step of streaming a sample liquid through the flow channel of the microfluidic device, in particular provided in the form of a microfluidic chip, and filling the array of reaction areas with the sample liquid in a successive manner by pushing the sample liquid through the flow channel, a subsequent step of streaming an initial sealing liquid through the flow channel of the microfluidic device, for sealing each reaction area after the same has been filled with the sample liquid, and for pushing remaining sample liquid out of the microfluidic device, a step of applying a thermocycling temperature profile to the array of reaction areas, and a step of pumping additional sealing liquid through the flow channel of the microfluidic device, for flushing gas bubbles out of the flow channel. Here, the step of applying a thermocycling temperature profile to the array of reaction areas and the step of pumping additional sealing liquid through the flow channel of the microfluidic device, for flushing gas bubbles out of the flow channel, can be provided in the course of a combined step, i.e. in case the application of a temperature to the array of reaction areas is achieved by means of pumping heated additional sealing liquid through the flow channel, wherein the pumping of the additional sealing liquid results in heating the sample liquid inside the reaction arrays and, at the same time, flushing gas bubbles out of the flow channel. Further preferably, the dPCR method of the present disclosure also comprises a step of assaying the biological sample provided in the array of reaction areas, thereby rendering the method to be an analysis method based on dPCR.
In accordance with a specific further embodiment, the step of pumping additional sealing liquid through the flow channel can comprise pumping a predetermined amount of additional sealing liquid through the flow channel on demand, wherein the step of pumping additional sealing liquid through the flow channel can either be a step of pumping additional sealing liquid through the flow channel constantly or a step of pumping additional sealing liquid through the flow channel intermittently, for example only when the sample liquid inside the reaction areas need to be tempered, and/or a step of pumping additional sealing liquid through the flow channel upon detection of gas bubbles in the flow channel. Here, with the possibility of pumping additional sealing liquid through the flow channel on demand, already existing gas bubbles inside the flow channel, or any kind of gas bubbles emerging during thermocycling of the sample inside the microfluidic device can be removed from the microfluidic device by flushing the flow channel with additional sealing liquid. Accordingly, with the method of the present disclosure, the negative influence of gas bubbles on the test results can at least be reduced or can be entirely avoided, thereby resulting in a significantly improved method for dPCR of a biological sample in the inventive microfluidic system.
According to a specific embodiment of the dPCR method of the present disclosure, the method can further comprise a step of monitoring and detecting the presence or generation of gas bubbles in the microfluidic device, for example by means of the detection device, e.g. in the form of an optical camera or the like, which can detect and/or monitor the presence or generation of gas bubbles inside the flow channel before and during thermocycling, provided that the flow channel allows an optical monitoring, i.e. the inside of the flow channel being visible from the outside, e.g. by means of a viewing window, transparent walls of the flow channel, or the like. Accordingly, the detection device can be used to provide a feedback signal indicating the occurrence of gas bubbles inside the flow channel, wherein the control unit can be triggered based on such feedback signal, resulting in a feedback-controlled dPCR method. Alternatively or additionally, the inventive method can further comprise a step of separating gas bubbles from the additional sealing liquid, for example by means of the bubble trap connected to the flow circuit downstream of the outlet of the microfluidic device. Thereby, any gas bubble flushed out of the flow channel of the microfluidic device by means of the streamed additional sealing liquid can be removed from the sealing liquid flowing inside the flow circuit. Accordingly, the optional step of separating gas bubbles from the additional sealing liquid by means of the bubble trap arranged in the fluid path of sealing liquid can be useful to immediately remove gas bubbles from the microfluidic system of the present disclosure, without the necessity to collect the sealing fluid exiting the microfluidic device and extract any gas bubbles therefrom at a later stage. Alternatively or additionally, the inventive method can also comprise a step of applying pressure onto the microfluidic device, for example by means of a pressure chamber surrounding at least the microfluidic device. The functionality of such an additional pressure applying step can add to the already achieved avoidance or removal ability of the inventive dPCR method, thereby further ensuring that gas bubbles do not disturb the test results. Hereby, the microfluidic device can be set under pressure of 1 to 2 bar, for example around 1.5 bar, in order to further suppress bubble generation during thermocycling, wherein the pressure can be applied onto the inside of the microfluidic device, either by applying pressure to a side wall of the flow channel acting as a flexible pressure transmitting component, or by means of applying pressure on the entire microfluidic device which, in such case, needs to exhibit a certain compressibility.
According to a specific embodiment of the dPCR method of the present disclosure, the step of applying a thermocycling temperature profile to the array of reaction areas can comprise a step of controlling the temperature profile of a thermal mount receiving the microfluidic device, for providing a thermocycling temperature profile to the array of reaction areas, or—alternatively—a step of controlling a heating and/or cooling device for heating and/or cooling of the sealing liquid temperature to a desired thermocycling temperature profile temperature. Here, the step of controlling a heating and/or cooling device can include one of the following options:
The above described microfluidic system of the present disclosure as well as the respective inventive method can be part of an automated processing system, such as an analytical, pre-analytical or post-analytical processing system, which is commonly employed in state-of-the-art laboratories for automatically processing biological samples, which can encompass any apparatus or apparatus component operable to execute one or more processing steps/workflow steps on one or more biological samples, and covers analytical instruments, pre-analytical instruments, and also post-analytical instruments. The expression “processing steps” thereby refers to physically executed processing steps, such as conducting the particular steps of a dPCR conduct. The term “analytical” as used herein encompasses any process step carried out by one or more laboratory devices or operative units which are operable to execute an analytical test on one or more biological samples. In the context of biomedical research, analytical processing is a technical procedure to characterize the parameters of a biological sample or of an analyte. Such characterization of parameter comprises, for example, the determination of the concentration of particular proteins, nucleic acids, metabolites, ions or molecules of various sizes in biological samples derived from humans or laboratory animals, or the like. The gathered information can be used to evaluate e.g. the impact of the administration of drugs on the organism or on particular tissues. Further analyses may determine optical, electrochemical or other parameters of the biological samples or the analytes comprised in the sample material.
The above described method steps can be controlled by the control unit of the described microfluidic system, which can also control any kind of actuation or monitoring of the above described microfluidic system and its components, wherein the term “control unit” as used herein encompasses any physical or virtual processing device, such as a CPU or the like, which can also control an entire laboratory instrument or even an entire workstation comprising one or more laboratory instruments in a way that workflow(s) and workflow step(s) are conducted. The control unit may, for example, carry different kinds of application software and instruct the automated processing system or a specific instrument or device thereof to conduct pre-analytical, post analytical and analytical workflow(s)/workflow step(s). The control unit may receive information from a data management unit regarding which steps need to be performed with a certain sample. Further, the control unit might be integral with a data management unit, may be comprised by a server computer and/or be part of one instrument or even distributed across multiple instruments of the automated processing system. The control unit may, for instance, be embodied as a programmable logic controller running a computer-readable program provided with instructions to perform operations. Here, in order to receive such instructions by a user, a user interface can additionally be provided, wherein the term “user interface” as used herein encompasses any suitable piece of application software and/or hardware for interactions between an operator and a machine, including but not limited to a graphical user interface for receiving as input a command from an operator and also to provide feedback and convey information thereto. Also, a system/device may expose several user interfaces to serve different kinds of users/operators.
As used herein and also in the appended claims, the singular forms “a”, “an”, and “the” include plural reference unless the context clearly dictates otherwise. Similarly, the words “comprise”, “contain” and “encompass” are to be interpreted inclusively rather than exclusively; that is to say, in the sense of “including, but not limited to”. Similarly, the word “or” is intended to include “and” unless the context clearly indicates otherwise. The terms “plurality”, “multiple” or “multitude” refer to two or more, i.e. 2 or >2, with integer multiples, wherein the terms “single” or “sole” refer to one, i.e. =1. Furthermore, the term “at least one” is to be understood as one or more, i.e. 1 or >1, also with integer multiples. Accordingly, words using the singular or plural number also include the plural and singular number, respectively. Additionally, the words “herein,” “above,”, “previously” and “below” and words of similar import, when used in this application, shall refer to this application as a whole and not to any particular portions of the application.
The description of specific embodiments of the present disclosure is not intended to be exhaustive or to limit the disclosure to the precise form disclosed. While the specific embodiments of, and examples for, the present disclosure are described herein for illustrative purposes, various equivalent modifications are possible within the scope of the disclosure as presented by the appended claims, as those skilled in the relevant art will recognize. Specific elements of any foregoing and later described embodiments can be combined or substituted for elements in other embodiments. Also, in drawings, same reference numerals denote same elements to avoid repetition, and parts readily implemented by one of ordinary skill in the art may be omitted. Furthermore, while advantages associated with certain embodiments of the disclosure have been described in the context of these embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the disclosure as defined by the appended claims.
The following examples are intended to illustrate specific embodiments of the present disclosure. As such, the specific implementations as discussed hereinafter are not to be construed as limitations on the scope of the present disclosure. It will be apparent to the person skilled in the art that various equivalents, changes, and modifications may be made without departing from the scope of the present disclosure as defined by the appended claims, and it is thus to be understood that such equivalent embodiments are to be included herein. Further aspects and advantages of the present disclosure will become apparent from the following description of particular embodiments illustrated in the figures.
The microfluidic system 1 further comprises a flow circuit 3 connected to the microfluidic device 2, wherein the flow circuit 3 is used for flowing additional sealing liquid 29 through the flow channel 25 of the microfluidic device 2, and mainly for flowing the additional sealing liquid 29 through the flow channel 25 of the microfluidic device 2. Here, the flow of additional sealing liquid 29 is illustrated by means of an arrow circle turning counter-clockwise. The additional sealing liquid 29 originates substantially from a secondary sealing liquid source 4 consisting of a tempered reservoir 41 comprising heated additional sealing liquid 29 and a non-tempered reservoir 42 comprising non-heated or cooled additional sealing liquid 29, wherein the reservoirs 41, 42 are connected to the flow circuit 3 by a respective electronically controlled delivery valve 411, 421. Thus, by controlling the delivery valve 411, heated additional sealing liquid 29 can be introduced into the flow circuit 3, and by controlling the delivery valve 421, non-heated additional sealing liquid 29 can be introduced into the flow circuit 3, thereby resulting in a desired temperature profile of the additional sealing liquid 29 inside the flow circuit 3. Alternatively, the tempered reservoir 41 and the non-tempered reservoir 42 can share a common mixing valve, which is then connected to the flow circuit 3, functioning in the sense of a mixing faucet, such that already premixed and, thus, accordingly tempered additional sealing liquid 29 is introduced into the flow circuit 3, ready to be provided to the microfluidic device 2.
Now, in order to provide the additional sealing liquid 29 to the flow channel 25, a peristaltic pump 31 functioning as pumping device of the microfluidic system 1 is provided as part of the flow circuit 3, for pumping the additional sealing liquid 29 to the microfluidic device 2, through its inlet 23 through the flow channel 25 and out of the outlet 24, thereby not only providing heat or cold to the array of reaction areas 26 for thermocycling of the samples inside the array of reaction areas 26, but also achieving a flushing of any gas bubbles, if occurring inside the flow channel 25, out of the flow channel 25 and the outlet 24, i.e. out of the microfluidic device 2. Here, the pump 31 can constantly pump the additional sealing liquid 29 through the flow channel 25, or can pump the additional sealing liquid 29 through the flow channel 25 intermittently, for example only when the sample liquid 27 inside the array of reaction areas 26 needs to be tempered. Thus, with the possibility of pumping additional sealing liquid 29 through the flow channel 25 on demand, already existing gas bubbles inside the flow channel 25, or any kind of gas bubbles emerging during thermocycling of the sample liquid 27, can be removed from the microfluidic device 2 by flushing the flow channel 25 with additional sealing liquid 29. In order to be able to finally remove any gas bubbles from the entire flow system, the microfluidic system 1 further comprises a bubble trap 32 arranged downstream of the outlet 24 of the microfluidic device 2 and, in the present embodiment, arranged before the pump 31, wherein the bubble trap 32 is used to separate any gas bubbles from the streamed additional sealing liquid 29. Thereby, gas bubbles, if any, can immediately be removed from the microfluidic system 1. Accordingly, any negative influence of gas bubbles on the test results can at least be reduced or can be entirely avoided.
In
According to an alternative embodiment, the structure of the previously described embodiment as shown in
While the current disclosure has been described in relation to its specific embodiments, it is to be understood that this description is for illustrative purposes only. It is therefore understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit or scope of the present disclosure as defined by the appended claims. Various publications are cited herein, the disclosures of which are incorporated herein by reference in their entireties.
Number | Date | Country | Kind |
---|---|---|---|
18189498.1 | Aug 2018 | EP | regional |